Cochrane Abstracts
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer New search for studies and content updated (no change to conclusions)
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer New search for studies and content updated (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Single or Combined Immune Checkpoint Inhibitors Compared to First‐line Platinum‐based Chemotherapy With or Without Bevacizumab for People With Advanced Non‐small Cell Lung Cancer New Search for Studies and Content Updated (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433368/all/Electrostimulation_for_promoting_recovery_of_movement_or_functional_ability_after_stroke:_Cochrane_systematic_review. Accessed 07 December 2022.
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer New search for studies and content updated (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/all/Electrostimulation_for_promoting_recovery_of_movement_or_functional_ability_after_stroke:_Cochrane_systematic_review. Accessed December 7, 2022.
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer New search for studies and content updated (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/all/Electrostimulation_for_promoting_recovery_of_movement_or_functional_ability_after_stroke:_Cochrane_systematic_review
Single or Combined Immune Checkpoint Inhibitors Compared to First‐line Platinum‐based Chemotherapy With or Without Bevacizumab for People With Advanced Non‐small Cell Lung Cancer New Search for Studies and Content Updated (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/all/Electrostimulation_for_promoting_recovery_of_movement_or_functional_ability_after_stroke:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer New search for studies and content updated (no change to conclusions)
ID - 433368
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433368/all/Electrostimulation_for_promoting_recovery_of_movement_or_functional_ability_after_stroke:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
